NYSE ARCA | ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities.
The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business.
The fund is non-diversified.
Top 18 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
MNMD | Mind Medicine Inc | Healthcare | Biotechnology | 12.25% |
CYBN | Cybin Inc | Healthcare | Biotechnology | 7.94% |
CYBN | Cybin Inc | Healthcare | Biotechnology | 7.55% |
ATAI | ATAI Life Sciences BV | Healthcare | Biotechnology | 6.49% |
ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 6.40% |
NRXP | NRX Pharmaceuticals Inc | Healthcare | Biotechnology | 5.84% |
TTTXX | BlackRock Liquidity Funds - Treasury Trust Fund | null | null | 5.27% |
QNTM | Quantum BioPharma Ltd Ordinary Shares - Class B (Sub Voting) | null | null | 5.20% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.90% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.82% |
GHRS | GH Research PLC | Healthcare | Biotechnology | 4.81% |
SAGE | Sage Therapeutic | Healthcare | Biotechnology | 4.56% |
CMPS | Compass Pathways Plc | Healthcare | Medical Care Facilities | 4.55% |
SLZA | ENVERIC BIOSCI.INC.DL-01 | Healthcare | Biotechnology | 3.49% |
NUMI | Numinus Wellness Inc | Healthcare | Medical Care Facilities | 1.21% |
RLMD | Relmada Therapeutics Inc | Healthcare | Biotechnology | 1.20% |
GBNH | Greenbrook TMS Inc | Healthcare | Medical Care Facilities | 0.26% |
PSYB | PSYBIO THERAP. (SUB.VT.) | 0.00% |